Archangels — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
1nhaler develops a single-dose dry powder inhaler made mostly from cardboard, designed to be low-cost, portable, propellant-free and low in carbon impact for delivering inhalable medicines.
HealthtechMedical DevicesNew Materials
Helen Muirhead(Chief Scientific Officer)Lars Larsson(Chief Medical Officer)
Bioliberty develops the Lifehub Clinic system, combining soft robotic wearables, gamified therapy, and AI insights to help clinicians deliver physical and occupational therapy to patients recovering from mobility issues such as stroke.
Digital HealthMedical DevicesRoboticsEdinburgh, GB
Rowan Armstrong(Founder)inShea Quinn(Founder)inRowan Armstrong, MEng, RAEng(Chief Executive Officer, Co-founder)Ross O'Hanlon, MEng(Chief Technology Officer, Co-founder)Conan Bradley, MEng(Chief Commercial Officer, Co-founder)Shéa Quinn, MEng(Chief Operating Officer, Co-founder)
Co-investorsBallad VenturesConduit ConnectScottish National Investment BankEos AdvisoryOld College Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
1inhalerAdministrate
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







